Skip to Content

Gardasil 9 Approval History

Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) is a 9-valent HPV vaccine for the prevention of cervical, vulvar, vaginal, and anal cancers caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58.

Development History and FDA Approval Process for Gardasil 9

DateArticle
Dec 15, 2015Approval FDA Approves Expanded Age Indication for Gardasil 9 in Males
Dec 10, 2014Approval FDA Approves Gardasil 9 for Prevention of Certain Cancers Caused by Five Additional Types of HPV

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide